cardiovascular system
• increase in length of cardiomyocytes without change in cell width, suggesting eccentric cardiac growth
|
• enlarged hearts at 4 and 10 months of age with wet heart weight-to-body weight ratios increased
|
• hearts show induction of fetal genes Nppa, Myh7 and Nppb, indicating cardiac hypertrophy
|
• left ventricular chamber dilation in adults
|
• early-onset cardiomyopathy that develops into dilated cardiomyopathy by 1 month of age
• hearts develop dilated phenotype showing a reduction in the ratio of left ventricular wall and septal thickness to left ventricle chamber radius which indicates eccentric cardiac growth
• however, no concentric hypertrophic growth or left ventricle wall thickening is seen, no changes in heart rate or mitral and aortic valve function are seen, no myocyte disarray or fibrosis, or cardiomyocyte proliferation and apoptosis alterations are seen
|
• systolic dysfunction with increases in left ventricular inner diameter at end diastole and end systole within one month of age
• decrease in fractional shortening at all ages examined, indicating defective cardiac function during perinatal and postnatal life
• systolic function impairment is seen as early as E17.5
• however, intraventricular septal or left ventricle posterior wall thickness is not changed
• passive force generation at a given sarcomere length in trabecular myocardium is similar to controls and myofilament calcium sensitivity is unaltered
|
mortality/aging
N |
• mice exhibit normal life span
|
muscle
• increase in length of cardiomyocytes without change in cell width, suggesting eccentric cardiac growth
|
• early-onset cardiomyopathy that develops into dilated cardiomyopathy by 1 month of age
• hearts develop dilated phenotype showing a reduction in the ratio of left ventricular wall and septal thickness to left ventricle chamber radius which indicates eccentric cardiac growth
• however, no concentric hypertrophic growth or left ventricle wall thickening is seen, no changes in heart rate or mitral and aortic valve function are seen, no myocyte disarray or fibrosis, or cardiomyocyte proliferation and apoptosis alterations are seen
|
• systolic dysfunction with increases in left ventricular inner diameter at end diastole and end systole within one month of age
• decrease in fractional shortening at all ages examined, indicating defective cardiac function during perinatal and postnatal life
• systolic function impairment is seen as early as E17.5
• however, intraventricular septal or left ventricle posterior wall thickness is not changed
• passive force generation at a given sarcomere length in trabecular myocardium is similar to controls and myofilament calcium sensitivity is unaltered
|
growth/size/body
• enlarged hearts at 4 and 10 months of age with wet heart weight-to-body weight ratios increased
|
• hearts show induction of fetal genes Nppa, Myh7 and Nppb, indicating cardiac hypertrophy
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:195548 |